Parsvnath Developers banned from securities market for six monthsThe regulator alleged that the company had failed to present true and fair financial statements, executed transactions that are non-genuine...
01 Jul, 2022, 06.35 AM IST
Blow to Roche's cancer immunotherapy prospects as 2nd trial failsIn a study, a combination of tiragolumab and Roche's established Tecentriq drug did not slow disease progression in newly diagnosed cases o...
11 May, 2022, 06.15 PM IST
SBI signs pact with three NBFC-MFIs for co-lending to joint liability groupsThe country's largest lender has signed the pact with Vedika Credit Capital Ltd (VCCL), Save Microfinance Pvt Ltd (SMPL) and Paisalo Digita...
29 Sep, 2021, 08.55 PM IST
Sebi gives six more months to Prabhat Dairy for delisting sharesIn October this year, PDL requested Sebi for six-month extension for filing the final application for delisting, citing the nationwide lock...
21 Dec, 2020, 10.40 PM IST
United Spirits proposes merger with its subsidiary Pioneer Distilleries LimitedThe maker of Johnie Walker and McDowell whiskey said in a company statement that the amalgamation scheme has been approved at its board mee...
02 Dec, 2019, 10.14 PM IST
World Cancer Day: Immunotherapy can help patients suffering from carcinoma of the lungsImmunotherapy should be given as early as possible to achieve a lasting remission of the disease.
04 Feb, 2019, 03.37 PM IST
Sebi refuses to grant stay on forensic audit of Parsvnath DevelopersThe company was given an opportunity in November last year to submit its explanation.
04 Jan, 2019, 06.10 PM IST
- Scientists develop new therapeutic antibody for dog cancers
Tokyo, Aug 26 (IANS) Japanese researchers have developed an antibody that induces immune responses, which significantly suppresses malignan...
26 Aug, 2017, 02.32 PM IST
Medical breakthrough! Aurigene closer to developing cancer treatment capsuleThe Bengaluru-based company is an independent subsidiary of Dr Reddy’s Laboratories and its United States-based partner Curis Inc.
01 Jul, 2016, 06.50 AM IST
United Spirits Ltd seeks shareholders' nod to guarantee PDL's Rs 100 crore loanThe loan would augment the production capacity of PDL, which would in turn secure supply of ENA (extra neutral alcohol) and IMFL to UK-base...
09 Dec, 2015, 07.57 PM IST
FIR against Parasvnath for cheating investorsParasvnath has come under the scanner of Delhi Police’s Economic Offence Wing (EOW) with the registration of an FIR against the company.
08 May, 2015, 05.45 AM IST
- CARE assigns IPO Grade 2 to Parabolic Drugs
CARE has assigned 'CARE IPO Grade 2' to the Rs 200 crore initial public offer of Parabolic Drugs Ltd, indicating 'Below Average Fundamental...
03 Jun, 2010, 11.57 AM IST
- Yatra in talks to buy stake in Parsvnath bus terminal project
Yatra Capital, the Euronext-quoted India-focused real estate fund, is in final round discussion with Parsvnath Developers (PDL) to pick up ...
31 Mar, 2008, 03.42 AM IST
- Lehman Bros, Morgan Stanley eye 40% of Parsvnath SEZs
Parsvnath Developers (PDL) is learnt to be in talks with US-based global financial investors Lehman Brothers and Morgan Stanley for divesti...
05 Oct, 2007, 01.36 AM IST
- Parabolic Drugs to invest Rs 100 cr on new units
Pharmaceuticals firm Parabolic Drugs Ltd (PDL) plans to infuse Rs 100 crore on setting up new facilities in Punjab and Himachal Pradesh as ...
16 Sep, 2007, 01.20 PM IST
- PDL launches Rs 50 cr luxury mall in Ahmedabad
Parsvnath Developers Ltd has launched a luxury shopping mall cum multiplex "Parsvnath City Centre" at a cost of Rs 50 crore in Vastrapur, A...
19 Jul, 2007, 02.25 PM IST
- Parsvnath to raise Rs 1,090 cr from its IPO
The company would raise Rs 1,090 crore at the higher band and about Rs 908 crore at the lower band.
27 Oct, 2006, 05.30 PM IST